Zhiyi Biotech Successfully Completes Phase I Clinical Trial of SK10 for the Treatment of Chemotherapy-induced Diarrhea
Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/zhiyi-biotech-successfully-completes-phase-i-clinical-trial-of-sk10-for-the-treatment-of-chemotherapy-induced-diarrhea-302189661.html
en | CH0038389992 | ZHIYI | boerse | 67932287 |
